LXRepair develops DNA repair biomarkers based on a unique functional multiplex approach on microarrays. Today we offer 3 different assays that cover 90% of DNA repair pathways. These assays are used to identify predictive biomarkers of response to cancer therapies (radio and chemotherapy, DNA repair inhibitors, …) and to help the pharmaceutical industry to develop more specific and efficient DNA repair inhibitors.
BIOPOLIS, 5 avenue du Grand Sablon, 30200 La Tronche
Targeted indications : Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Brain cancer, Head and neck cancers, Skin cancer